NCT05812053 Comparative Evaluation of Eggshell Powder in Primary Teeth Pulpotomy
| NCT ID | NCT05812053 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tanta University |
| Condition | Pulpitis Reversible |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2023-04-01 |
| Primary Completion | 2026-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2023-04-01 with a primary completion date of 2026-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To assess \& compare clinical \& radiographic effects of Eggshell Powder, Biodentine and MTA as pulpotomy agents in primary teeth.
Eligibility Criteria
Inclusion Criteria: * Restorable primary molars with deep carious lesions. * Absence of gingival swelling or sinus tract. * Absence of spontaneous pain * Absence of pain on percussion. * Absence of discontinuity of lamina dura * Absence of internal root resorption. * Absence of external root resorption. * Absence of inter-radicular or periapical bone destruction (radiolucency). Exclusion Criteria: * presence of spontaneous pain * presence of gingival swelling or sinus tract * presence of internal or external root resorption * pain on percussion.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05812053 clinical trial?
This trial is open to participants of all sexes, aged 4 Years or older, up to 7 Years, studying Pulpitis Reversible. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05812053 currently recruiting?
Yes, NCT05812053 is actively recruiting participants. Contact the research team at shaimaaeldesouky@dent.tanta.edu.eg for enrollment information.
Where is the NCT05812053 trial being conducted?
This trial is being conducted at Tanta, Egypt.
Who is sponsoring the NCT05812053 clinical trial?
NCT05812053 is sponsored by Tanta University. The trial plans to enroll 30 participants.